Westfield Capital Management CO LP Orchard Therapeutics PLC Transaction History

Westfield Capital Management CO LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$5.75 - $11.99 $4.18 Million - $8.73 Million	-727,736 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $193,292 - $537,454	-34,211 Reduced 4.49%	727,736 $5.48 Million
Q4 2019 Feb 13, 2020	SELL	$10.15 - $15.58 $3.2 Million - $4.91 Million	-315,164 Reduced 29.26%	761,947 $10.5 Million
Q3 2019 Nov 08, 2019	BUY	$11.88 - $16.72 $389,367 - $547,998	32,775 Added 3.14%	1,077,111 $12.8 Million
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $6.89 Million - $10.8 Million	521,646 Added 99.8%	1,044,336 $14.6 Million
Q1 2019 May 14, 2019	BUY	$12.01 - $19.49 $6.28 Million - $10.2 Million	522,690 New	522,690 $9.35 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.